{"title":"TAP综合毛细血管血液采集系统","authors":"T. Richards","doi":"10.1097/POC.0000000000000176","DOIUrl":null,"url":null,"abstract":"T he drive for health care providers to streamline workflow, improve efficiency, and reduce costs has never been greater. At the same time, the trend toward decentralized health care is accelerating, most notably within consumer-focused care across all settings. The result is an emerging demand for rapid, reliable blood collection and diagnostic capabilities both inside and outside traditional clinical settings to improve access to high-quality diagnostic information. So far, however, much of the transition has been slowed by the limitations inherent in phlebotomy and finger-stick sampling. Both require trained personnel, involve multiple steps, disrupt workflow, and are the primary source of preanalytical errors in diagnostic testing. Worse, these methods are inconvenient as well as create anxiety and discomfort for patients. It is estimated that at least 10% of the US population suffer from needle phobia, and the number is reported to be much greater as sufferers tend to avoid medical treatment altogether. This is a significant impediment to a patient's ability to access the health care system. To address the limitations of both venipuncture and fingerstick sampling, Seventh Sense Biosystems set out to create a blood collection device that can be easily self-administered and is a painless method for collecting blood both within and outside traditional health care settings. Seventh Sense's TAP platform is designed to address theworkflow and quality challenges; facilitate the shift to decentralized, self-administered blood collection; and most importantly expand the reach of blood-based diagnostics to those who need it.","PeriodicalId":20262,"journal":{"name":"Point of Care: The Journal of Near-Patient Testing & Technology","volume":"9 1","pages":"132–135"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"The TAP Integrated Capillary Blood Collection System\",\"authors\":\"T. Richards\",\"doi\":\"10.1097/POC.0000000000000176\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"T he drive for health care providers to streamline workflow, improve efficiency, and reduce costs has never been greater. At the same time, the trend toward decentralized health care is accelerating, most notably within consumer-focused care across all settings. The result is an emerging demand for rapid, reliable blood collection and diagnostic capabilities both inside and outside traditional clinical settings to improve access to high-quality diagnostic information. So far, however, much of the transition has been slowed by the limitations inherent in phlebotomy and finger-stick sampling. Both require trained personnel, involve multiple steps, disrupt workflow, and are the primary source of preanalytical errors in diagnostic testing. Worse, these methods are inconvenient as well as create anxiety and discomfort for patients. It is estimated that at least 10% of the US population suffer from needle phobia, and the number is reported to be much greater as sufferers tend to avoid medical treatment altogether. This is a significant impediment to a patient's ability to access the health care system. To address the limitations of both venipuncture and fingerstick sampling, Seventh Sense Biosystems set out to create a blood collection device that can be easily self-administered and is a painless method for collecting blood both within and outside traditional health care settings. Seventh Sense's TAP platform is designed to address theworkflow and quality challenges; facilitate the shift to decentralized, self-administered blood collection; and most importantly expand the reach of blood-based diagnostics to those who need it.\",\"PeriodicalId\":20262,\"journal\":{\"name\":\"Point of Care: The Journal of Near-Patient Testing & Technology\",\"volume\":\"9 1\",\"pages\":\"132–135\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Point of Care: The Journal of Near-Patient Testing & Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/POC.0000000000000176\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Point of Care: The Journal of Near-Patient Testing & Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/POC.0000000000000176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
医疗保健提供者精简工作流程、提高效率和降低成本的动力从未如此强烈。与此同时,分散医疗保健的趋势正在加速,最明显的是在所有环境中以消费者为中心的医疗保健。其结果是在传统临床环境内外都出现了对快速、可靠的血液采集和诊断能力的新需求,以改善获得高质量诊断信息的机会。然而,到目前为止,由于静脉切开术和手指棒取样固有的局限性,这种转变在很大程度上放慢了速度。两者都需要训练有素的人员,涉及多个步骤,扰乱工作流程,并且是诊断测试中分析前错误的主要来源。更糟糕的是,这些方法不仅不方便,而且会给患者带来焦虑和不适。据估计,至少有10%的美国人患有针头恐惧症,据报道,由于患者倾向于完全避免就医,这一数字要大得多。这对患者利用卫生保健系统的能力是一个重大障碍。为了解决静脉穿刺和手指穿刺取样的局限性,第七感生物系统公司(Seventh Sense Biosystems)着手制造一种采血装置,这种装置可以很容易地自我给药,是一种在传统医疗机构内外采集血液的无痛方法。第七感的TAP平台旨在解决工作流程和质量挑战;促进向分散、自我管理的采血转变;最重要的是,将基于血液的诊断扩大到那些需要它的人。
The TAP Integrated Capillary Blood Collection System
T he drive for health care providers to streamline workflow, improve efficiency, and reduce costs has never been greater. At the same time, the trend toward decentralized health care is accelerating, most notably within consumer-focused care across all settings. The result is an emerging demand for rapid, reliable blood collection and diagnostic capabilities both inside and outside traditional clinical settings to improve access to high-quality diagnostic information. So far, however, much of the transition has been slowed by the limitations inherent in phlebotomy and finger-stick sampling. Both require trained personnel, involve multiple steps, disrupt workflow, and are the primary source of preanalytical errors in diagnostic testing. Worse, these methods are inconvenient as well as create anxiety and discomfort for patients. It is estimated that at least 10% of the US population suffer from needle phobia, and the number is reported to be much greater as sufferers tend to avoid medical treatment altogether. This is a significant impediment to a patient's ability to access the health care system. To address the limitations of both venipuncture and fingerstick sampling, Seventh Sense Biosystems set out to create a blood collection device that can be easily self-administered and is a painless method for collecting blood both within and outside traditional health care settings. Seventh Sense's TAP platform is designed to address theworkflow and quality challenges; facilitate the shift to decentralized, self-administered blood collection; and most importantly expand the reach of blood-based diagnostics to those who need it.